Your browser doesn't support javascript.
loading
Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
Kawaguchi, Sho; Kawahara, Kenta; Fujiwara, Yukio; Ohnishi, Koji; Pan, Cheng; Yano, Hiromu; Hirosue, Akiyuki; Nagata, Masashi; Hirayama, Masatoshi; Sakata, Junki; Nakashima, Hikaru; Arita, Hidetaka; Yamana, Keisuke; Gohara, Shunsuke; Nagao, Yuka; Maeshiro, Manabu; Iwamoto, Asuka; Hirayama, Mayumi; Yoshida, Ryoji; Komohara, Yoshihiro; Nakayama, Hideki.
Afiliación
  • Kawaguchi S; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Kawahara K; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan. karapote@kuh.kumamoto-u.ac.jp.
  • Fujiwara Y; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Ohnishi K; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Pan C; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Yano H; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Hirosue A; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Nagata M; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Hirayama M; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Sakata J; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Nakashima H; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Arita H; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Yamana K; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Gohara S; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Nagao Y; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Maeshiro M; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Iwamoto A; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Hirayama M; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Yoshida R; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan.
  • Komohara Y; Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan. ycomo@kumamoto-u.ac.jp.
  • Nakayama H; Department of Oral and Maxillofacial Surgery, Faculty of Life Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto, 860-8556, Japan. hinakaya@kumamoto-u.ac.jp.
Cancer Immunol Immunother ; 71(9): 2127-2139, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35044489

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Boca / Carcinoma de Células Escamosas Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Japón